← Brevix

MNT Weekly Delta — 2026-06-14

Molecular nanotechnology · lookback window Dec 2025 – 14 Jun 2026 · technology-intelligence delta

First run. No nano_seen_items.md existed in the working folder, so this is the initial MNT briefing — every item below is reported for the first time and seeded into memory. Subsequent runs will be true deltas. Evidence tiers: Demonstrated peer-reviewed/replicated · Reported preprint/single-source/vendor · Projected roadmap.

1 · Summary

2 · New technical developments

Atomically precise manufacturing & mechanosynthesis

De novo protein design & engineered protein nanomachines

Structural DNA/RNA nanotechnology

Molecular machines, motors & switches

Enabling tools — imaging, characterization, AI design

3 · New commercial activity

CompanyWhat they doStage / fundingThis window's updateTier
CBN Nano TechnologiesMechanosynthesis / APM (carbon structures by STM)Backed by Canada's Strategic Innovation Fund & Canadian Bank Note Co.Posted the additive-mechanosynthesis preprint — the window's central MNT claimReported
Skape BioAI-designed GPCR biotherapeutics (IPD miniprotein platform)New spinout, launched 21 May 2026Public launch alongside the Nature GPCR-miniprotein paperReported

Institute for Protein Design (UW) remains the dominant productive engine in designed protein nanomachines (three Nature outputs in-window). Foresight Institute continues bio/nano fast grants and APM advocacy; no new in-window roadmap or large grant verified. Zyvex Labs' ZyvexLitho1 remains the commercial APM-lithography reference but had no fresh 2026 announcement (latest hard news 2022).

4 · New institutional / policy items

No new MNT-specific government program, NNI action, or major grant was verified in-window. The most consequential institutional signal is funding-adjacent rather than policy: CBN's continued state-linked backing and the IPD→Skape Bio spinout. No MNT M&A verified this window.

5 · Quiet areas

6 · Sources

Confidence note: Source quality is mixed-to-good — the protein-design items rest on peer-reviewed Nature papers (high confidence); the headline mechanosynthesis result and several DNA items are preprints/single-source (treat as Reported, contested until replicated). The RNA-fueled DNA engine is feed-confirmed only. Lab and author self-summaries were used for context but the underlying Nature/arXiv records are the primary sources. report.css could not be inlined this run (outside mounted folder); a self-contained fallback style was used.